Susquehanna International Group
NEOS

Susquehanna International Group’s Neos Therapeutics, Inc NEOS Stock Holding History

Susquehanna International Group’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-87,800
Closed -$55K – 13196
2020
Q4 		$55K Buy
+87,800
New +$54.2K ﹤0.01% 10729
2019
Q2 		– Sell
-28,200
Closed -$74K – 11119
2019
Q1 		$74K Buy
+28,200
New +$66.1K ﹤0.01% 8363
2018
Q1 		– Sell
-16,400
Closed -$167K – 10551
2017
Q4 		$167K Buy
16,400
+4,800
+41% +$46.1K ﹤0.01% 8419
2017
Q3 		$106K Sell
11,600
-3,100
-21% -$23.6K ﹤0.01% 8337
2017
Q2 		$107K Buy
+14,700
New +$111K ﹤0.01% 8663

Susquehanna International Group's NEOS Position: Q1 2021 in Review

Susquehanna International Group sold out of Neos Therapeutics, Inc (NEOS) in Q1 2021, closing a stake of 245,105 shares — an estimated $153K sold.

Susquehanna International Group first reported a position in NEOS in Q4 2016 and held it in 9 quarters. The position peaked at $2.33M in Q3 2017. 0 funds tracked by Wall St. Rank hold NEOS as of Q1 2021.

  • Susquehanna International Group reported no remaining Neos Therapeutics, Inc position as of Q1 2021 after selling out during the quarter.
  • Susquehanna International Group sold 245,105 Neos Therapeutics, Inc shares in Q1 2021, an estimated $153K.
  • Susquehanna International Group first reported a position in Neos Therapeutics, Inc in Q4 2016 and held it in 9 quarters.
  • Susquehanna International Group's Neos Therapeutics, Inc position peaked at $2.33M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q1 2021.

Based on Susquehanna International Group's 13F filing for Q1 2021, filed 17 May 2021.